These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12718409)

  • 1. Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system.
    Romero MR; Martinez-Diez MC; Larena MG; Macias RI; Dominguez M; Garcia-Monzon C; Serrano MA; Marin JJ
    Antivir Chem Chemother; 2002 Nov; 13(6):371-80. PubMed ID: 12718409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
    Delaney WE; Miller TG; Isom HC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
    Yan SN; Deng B; Gong ZJ
    Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
    Huang YQ; Wang LW; Yan SN; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
    Ren S; Nassal M
    J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
    Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells.
    Briz O; Serrano MA; Rebollo N; Hagenbuch B; Meier PJ; Koepsell H; Marin JJ
    Mol Pharmacol; 2002 Apr; 61(4):853-60. PubMed ID: 11901224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism.
    Monte MJ; Ballestero MR; Briz O; Perez MJ; Marin JJ
    J Pharmacol Exp Ther; 2005 Oct; 315(1):24-35. PubMed ID: 15985617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
    Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
    Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus.
    Delaney WE; Isom HC
    Hepatology; 1998 Oct; 28(4):1134-46. PubMed ID: 9755254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
    J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hepatocellular carcinoma cell line producing mature hepatitis B viral particles.
    Fellig Y; Almogy G; Galun E; Ketzinel-Gilad M
    Biochem Biophys Res Commun; 2004 Aug; 321(2):269-74. PubMed ID: 15358171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences.
    Mabit H; Dubanchet S; Capel F; Dauguet C; Petit MA
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2681-9. PubMed ID: 7931154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
    Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
    Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.
    Romero MR; Efferth T; Serrano MA; Castaño B; Macias RI; Briz O; Marin JJ
    Antiviral Res; 2005 Nov; 68(2):75-83. PubMed ID: 16122816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells.
    Rang A; Günther S; Will H
    J Hepatol; 1999 Nov; 31(5):791-9. PubMed ID: 10580575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.